Impaired insight into illness is unrelated to subjective happiness, success, and life satisfaction in schizophrenia.


Journal

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
ISSN: 1547-3325
Titre abrégé: Ann Clin Psychiatry
Pays: United States
ID NLM: 8911021

Informations de publication

Date de publication:
11 2022
Historique:
entrez: 25 10 2022
pubmed: 26 10 2022
medline: 28 10 2022
Statut: ppublish

Résumé

Impaired insight into illness is a common feature of schizophrenia. Improved insight is associated with better treatment adherence and clinical outcomes. At the same time, improving insight has been suggested to increase depressive symptoms and diminish quality of life. The aim of this study was to examine the associations between impaired insight and degree of subjective happiness, perceived level of success, and life satisfaction in patients with schizophrenia spectrum disorders. A total of 108 participants with schizophrenia or schizoaffective disorder were included. Data for this study were obtained from our group's previous investigation that examined the relationship between impaired insight and visuospatial attention. Insight into illness was measured by the VAGUS scale, which assesses general illness awareness, accurate symptom attribution, awareness of the need for treatment, and awareness of the negative consequences attributable to the illness. Our results revealed no association among the VAGUS average and subscale scores and degree of subjective happiness, perceived level of success, and life satisfaction. Our study suggests that insight into illness is not related to subjective happiness, life satisfaction, or perceived level of success in patients with schizophrenia, which is in contrast to previous reports that demonstrate an association between insight into illness and depression.

Sections du résumé

BACKGROUND
Impaired insight into illness is a common feature of schizophrenia. Improved insight is associated with better treatment adherence and clinical outcomes. At the same time, improving insight has been suggested to increase depressive symptoms and diminish quality of life. The aim of this study was to examine the associations between impaired insight and degree of subjective happiness, perceived level of success, and life satisfaction in patients with schizophrenia spectrum disorders.
METHODS
A total of 108 participants with schizophrenia or schizoaffective disorder were included. Data for this study were obtained from our group's previous investigation that examined the relationship between impaired insight and visuospatial attention. Insight into illness was measured by the VAGUS scale, which assesses general illness awareness, accurate symptom attribution, awareness of the need for treatment, and awareness of the negative consequences attributable to the illness.
RESULTS
Our results revealed no association among the VAGUS average and subscale scores and degree of subjective happiness, perceived level of success, and life satisfaction.
CONCLUSIONS
Our study suggests that insight into illness is not related to subjective happiness, life satisfaction, or perceived level of success in patients with schizophrenia, which is in contrast to previous reports that demonstrate an association between insight into illness and depression.

Identifiants

pubmed: 36282606
pii: acp.0081
doi: 10.12788/acp.0081
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-239

Subventions

Organisme : CIHR
Pays : Canada

Auteurs

Julia Kim (J)

Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.

Laura Romero (L)

Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Yusuke Iwata (Y)

Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Fernando Caravaggio (F)

Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Gary Remington (G)

Multimodal Imaging Group, Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Department of Psychiatry, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.

Ariel Graff-Guerrero (A)

Department of Psychiatry, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Multimodal Imaging Group, Research Imaging Centre, Campbell Family Mental Health Research Institute, Geriatric Mental Health Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Philip Gerretsen (P)

Multimodal Imaging Group, Research Imaging Centre, Campbell Family Mental Health Research Institute, Geriatric Mental Health Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Department of Psychiatry, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.

Ofer Agid (O)

Department of Psychiatry, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH